ES2512590T3 - Combinación de extractos vegetales específica de compartimento de extracto de Ginkgo biloba y ginseng con efecto de tipo tándem - Google Patents
Combinación de extractos vegetales específica de compartimento de extracto de Ginkgo biloba y ginseng con efecto de tipo tándem Download PDFInfo
- Publication number
- ES2512590T3 ES2512590T3 ES08801930.2T ES08801930T ES2512590T3 ES 2512590 T3 ES2512590 T3 ES 2512590T3 ES 08801930 T ES08801930 T ES 08801930T ES 2512590 T3 ES2512590 T3 ES 2512590T3
- Authority
- ES
- Spain
- Prior art keywords
- combination
- ginkgo biloba
- plant extracts
- ginseng extract
- specific plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
Abstract
Combinación con efecto específico de compartimento de extractos de Ginkgo biloba y ginseng, caracterizada por que están presentes Ginkgo en forma de un extracto de acetona-agua con una PFE de 40-53:1 y ginseng como extracto de etanol-agua con una PFE de 3,3-3,8:1 y la proporción (en peso) de extracto de ginseng a extracto de Ginkgo es £ 1:1.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008020127 | 2008-04-22 | ||
DE102008020127A DE102008020127A1 (de) | 2008-04-22 | 2008-04-22 | Kompartimentspezifische Pflanzenextraktkombination aus Ginkgo biloba- und Ginseng-Extrakt mit Tandemwirkung |
PCT/EP2008/007357 WO2009129833A1 (de) | 2008-04-22 | 2008-09-09 | Kompartimentspezifische pflanzenextraktkombination aus ginkgo biloba- und ginseng-extrakt mit tandemwirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2512590T3 true ES2512590T3 (es) | 2014-10-24 |
Family
ID=40070935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES08801930.2T Active ES2512590T3 (es) | 2008-04-22 | 2008-09-09 | Combinación de extractos vegetales específica de compartimento de extracto de Ginkgo biloba y ginseng con efecto de tipo tándem |
Country Status (7)
Country | Link |
---|---|
US (1) | US9592261B2 (es) |
EP (1) | EP2282751B1 (es) |
DE (1) | DE102008020127A1 (es) |
ES (1) | ES2512590T3 (es) |
PL (1) | PL2282751T3 (es) |
RU (1) | RU2485965C2 (es) |
WO (1) | WO2009129833A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010048283A1 (de) * | 2010-10-14 | 2012-04-19 | Schaper & Brümmer GmbH & Co. KG | Kaufähige Tablette |
CN105687647A (zh) * | 2014-11-26 | 2016-06-22 | 上海中医药大学 | 青娥丸抗抑郁抗焦虑的新用途 |
CN104825806A (zh) * | 2015-04-18 | 2015-08-12 | 于巧媛 | 一种治疗肾精不足型眩晕病的中药 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0016471A (pt) | 1999-12-17 | 2002-08-20 | Combinação de ginseng e ginkgo para melhorar habilidades cognitivas | |
US6617356B2 (en) * | 2000-01-03 | 2003-09-09 | Naturally Scientific Inc | Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements |
RU2188564C2 (ru) * | 2000-07-19 | 2002-09-10 | Закрытое акционерное общество "Эвалар" | Биологически активная добавка к пище для профилактики и уменьшения метеозависимости, чувствительности к солнечным и геомагнитным бурям |
CN1127971C (zh) * | 2001-06-15 | 2003-11-19 | 薛志祥 | 一种治疗老年痴呆的药物 |
JP2003038140A (ja) | 2001-07-31 | 2003-02-12 | I-Deal Coms Kk | エゾウコギを含む栄養飲料 |
ES2287403T3 (es) | 2003-12-04 | 2007-12-16 | Cognis Ip Management Gmbh | Metodo para la produccion de extractos de ginkgo biloba. |
DE102006019863A1 (de) | 2005-05-03 | 2006-11-16 | Bioplanta Arzneimittel Gmbh | Verbessertes Verfahren zur Herstellung von Ginkgoextrakten mit vermindertem Gehalt an polycyclischen aromatischen Kohlenwasserstoffen |
WO2007045959A2 (en) * | 2005-10-21 | 2007-04-26 | Fx Life Sciences International Gmbh | Antioxidant and fe2+chelating properties of herbal extracts |
EP2033653B1 (en) | 2006-04-19 | 2013-09-11 | Shineway Pharmaceutical Group Ltd. | A chinese medicine composition and preparation method and use thereof |
US20080031978A1 (en) | 2006-04-20 | 2008-02-07 | Chou Wen H | Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders |
-
2008
- 2008-04-22 DE DE102008020127A patent/DE102008020127A1/de not_active Withdrawn
- 2008-09-09 ES ES08801930.2T patent/ES2512590T3/es active Active
- 2008-09-09 RU RU2010147395/15A patent/RU2485965C2/ru active
- 2008-09-09 WO PCT/EP2008/007357 patent/WO2009129833A1/de active Application Filing
- 2008-09-09 US US12/736,440 patent/US9592261B2/en active Active
- 2008-09-09 EP EP08801930.2A patent/EP2282751B1/de active Active
- 2008-09-09 PL PL08801930T patent/PL2282751T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
RU2010147395A (ru) | 2012-05-27 |
US9592261B2 (en) | 2017-03-14 |
DE102008020127A1 (de) | 2009-11-05 |
EP2282751B1 (de) | 2014-07-09 |
PL2282751T3 (pl) | 2014-12-31 |
US20110034563A1 (en) | 2011-02-10 |
EP2282751A1 (de) | 2011-02-16 |
RU2485965C2 (ru) | 2013-06-27 |
WO2009129833A1 (de) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2540751T3 (es) | Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng | |
ES2545975T3 (es) | Composición que contiene piceatannol y procedimiento para producir la composición que contiene piceatannol | |
CR20110163A (es) | Uso de ditiina-tetracarboxamidas para combatir hongos fitopatógenos | |
HN2011001251U (es) | Bloque de muro de contención de múltiples componentes | |
AR077541A1 (es) | Aditamento para maquina cosechadora | |
ES2623025T3 (es) | Comprimido de desintegración oral que contiene acarbosa | |
BRPI1010369B8 (pt) | composição cosmética em forma de nanoemulsão óleo-em-água e uso de uma composição | |
AU355139S (en) | Chair | |
ES2512590T3 (es) | Combinación de extractos vegetales específica de compartimento de extracto de Ginkgo biloba y ginseng con efecto de tipo tándem | |
CL2014000606A1 (es) | Combinacion farmaceutica que comprende al compuesto 2-{2-[(2s)-2-metil-2,3-dihidro-1h-indol-1-il]-2-oxoetil}-6-(morfolin-4-il)pirimidin-4-(3h)-ona y al menos un inhibidor de la via de mapk; composicion farmaceutica; kit farmaceutico; su uso en el tratamiento del cancer. | |
AU339577S (en) | Organ transporter | |
AU327779S (en) | Bar table | |
AU324429S (en) | Writing instrument | |
AU321830S (en) | Bottle | |
CO6331392A2 (es) | Estructura impresa para realizar productos varios, contenedores para productos, etiquetas y similares | |
PE20160229A1 (es) | Aleacion de zinc con firma electromagnetica unica y conductividad reducida | |
ES2523469B1 (es) | Producto anticelulítico a base de esencias naturales | |
CL2012000350A1 (es) | Combinacion farmaceutica que comprende un compuesto derivado de bifenilamida y un agente inhibidor de bcr-abl seleccionado de nilotinib; composicion farmaceutica; y uso de la combinacion para el tratamiento de leucemia positiva a bcr-abl. | |
CL2011003334A1 (es) | Proceso para elaborar un nanorefuerzo natural, a partir de silicato natural de origen volcánico del tipo montmorillonita sódica con tamaño bajo 2 µm que comprende fraccionamiento y tratamiento en húmedo, incorporando solamente un defloculante– floculante a temperatura ambiente; el nanorefuerzo y su uso para producir nanocompositos. | |
ES2542777T3 (es) | Bebida | |
ES2526940A1 (es) | Jabón desodorante | |
BR112015015728A2 (pt) | processo para produzir ácido acrílico | |
AU340258S (en) | Refill for air freshener device | |
RU2008144051A (ru) | Средство, обладающее иммуностимулирующим действием | |
AU319379S (en) | Lavatory |